The use of remifentanil in general anesthesia for cesarean section in a parturient with severe mitral stenosis and pulmonary edema

Middle East Journal of Anesthesiology

Volumn 20, Issue 4, 2010, Pages 585-588

  Amini, Shahram ^a   Yaghmaei, Minoo ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cesarean section; General anesthesia; Mitral stenosis; Pulmonary edema; Remifentanil

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; PIPERIDINE DERIVATIVE; REMIFENTANIL;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; FEMALE; GENERAL ANESTHESIA; HOSPITALIZATION; HUMAN; LUNG EDEMA; METHODOLOGY; MITRAL VALVE STENOSIS; OBSTETRIC ANESTHESIA; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; ANESTHESIA, GENERAL; ANESTHESIA, OBSTETRICAL; ANESTHETICS, INTRAVENOUS; CESAREAN SECTION; FEMALE; HUMANS; MITRAL VALVE STENOSIS; PIPERIDINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULMONARY EDEMA; SEVERITY OF ILLNESS INDEX;

EID: 77950380379     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Draisci G, Valente A, Suppa E, et al: Remifentanil for cesarean section under genera anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. International J of Obs Anesth; 2008, 17:130-136.
2. Vogl SE, Worda C, Egarter C, et al: Mode of delivery is associated with maternal and fetal endocrine stress response. Brit J Obst Gyn; 2006, 113:441-5.
3. Morishima HO, Pederson H, Finster M, et al: Influence of maternal physiologic stress on the fetus. Am J Obstet Gynecol; 1978, 131:286-90.
4. Stanely TH, Webster LR: Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepamoxygen anesthesia in man. Anesth Analg; 1978, 57:411-6.
5. Schuttler J, Albrecht S, Breivik H, et al: A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anesthesia; 1997, 52:307-17.
6. Desai DJ, Golwala MP, Dhimar AA, Swadia VN: Emergency LSCS in a patient with severe mitral stenosis with pulmonary hypertension with aortic regurgitation (NYHA-III). Indian J Anesth; 2002, 46(6):483-485.
7. Soler-Soler J, Galve E: Worldwide perspective of valve disease. Heart; 2000, 83:721-25.
8. Thorne SA. Pregnancy in heart disease. Heart; 2004, 90:450-56.
9. Desai DK, Adanlawo M, Naidoo DP, Moodley J, Kleinschmidt I: Mitral stenosis in pregnancy: a four year experience at King Edward VIII hospital, Durban, South Africa. Brit J Obstet Gynecol; 2000, 107:953-58.
10. Sawhney H, Aggrawal N, Suri V, et al: Maternal and perinatal outcome in rheumatic heart disease. Int J Gynecol Obstet; 2003, 80:9-14.
11. Kuczkowski KM: Labor anesthesia for the parturient with cardiac disease: what does an obstetrician need to know? Acta Obstet Ansthesol Belg; 2004, 40:201-5.
12. Kuzczkowski KM, Zundert AV: Anesthesia for pregnant women with valvular heart disease: the state of the art. Journal of anesthesia; 2007, 21(2):52-57.
13. Nagan KeeW, Khaw KS, Ma KC, Wong AS, et al: Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial. Anesthesiology; 2006, 104:1014-20.
14. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP: Intravenous remifentanil. Placental transfer, maternal and neonatal effects. Anesthesiology; 1998, 88:1467-74.
15. Egan TD, Lemmens HJM, Fiset P, et al: The pharmacokinetics of the new short-acting opioid remifentanil in healthy adult male volunteers. Anesthesiology; 1993, 79:881-92.
16. More RMLE, Grange CS, Anisworth QP, Grebenik CR: General anesthesia using remifentanil for cesarean section in parturients with critical aortic stenosis: a series of four cases. Inter J Obstet Anesth; 2004, 13:183-7.
17. Bedard JM, Richardson MG, Wissler RN: General anesthesia with remifentanil for cesarean section in a parturient with an acoustic neuroma. Can J Anesth; 1999, 46(6):576-80.
18. Manullang TR, Chun K, Egan TD: The use of remifentanil for cesarean section in a parturient with recurrent aortic coarctation. Can J Anesth; 2000, 47(5): 454-59.
19. Scott H, Bateman C, Price M: The use of remifentanil in general anesthesia for cesarean section in a patient with mitral valve disease. Anesthesia; 1998, 53(7):695-7.
20. Molins EJ, Soria GA, Alcala E, Martinez EC, Sanchez CL: Anesthesia for cesarean delivery in a woman with congenital aortic stenosis. Res Esp Anestesiol; 2004, 51(4):221-5.
21. Mertens E, Saldien V, Coppejans H, Bettens K, Vercauteren M: Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension. Acta Anesthesiol Belg; 2001, 52(2):207-9.
22. Van de Velde M, Teunkens A, Kuypers M, et al: General anesthesia with target controlled infusion of propofol for planned cesarean section: maternal and neonatal effects of a remifentanil-based technique. Int J Obstet Anesth; 2004, 13:153-8.
23. Carvalho B, Mirikitani EJ, Lyell D, Evans DA, Druzin M, Riley ET: Neonatal chest wall rigidity following the use of remifentanil for cesarean delivery in a patient with autoimmune hepatitis and thrombocytopenia. Int J Obstet Anesth; 2004, 13(1):53-56.
24. Imarengiaye C, Littleford J, Davies S, Thaper K, Kingdom J: Goal oriented general anesthesia for cesarean section in a parturient with a large intracranial epidermoid cyst. Can J Anaesth; 2001, 48(9):884-889.